International firms catch flak in China Targeting profitable foreign firms operating in China at a time of slowing economic growth seems counterproductive and is a reversal from the past. September 20, 2015
GSK offers $1 billion to raise stake in Indian unit The UK-listed group offers to raise its stake in GlaxoSmithKline Pharmaceuticals, its Indian drug unit, boosting its investment in the country. December 16, 2013
Glaxo forms vaccine JV with Chinese firm GlaxoSmithKline and Shenzhen Neptunus will create a joint venture to make influenza vaccines for Greater China. June 09, 2009